GlassScriptPhysician profile
William A Martin
NPI 1336559327
$6,907.12
in general payments reported to CMS, 2019-2025
35 companies · $1,354 in 2025
The $1,354 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,039 · 2020: $468 · 2021: $115 · 2022: $857 · 2023: $1,447 · 2024: $1,628 · 2025: $1,354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,428.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,325.97 | 2019-2025 | |
| Pfizer INC. | $946.35 | 2019-2025 | |
| Tris Pharma INC | $537.90 | 2022-2025 | Dyanavel Xr |
| Novo Nordisk INC | $523.84 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $512.79 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $463.32 | 2019-2025 | Jardiance, Ofev |
| Amgen INC. | $437.66 | 2019-2025 | Evenity, Prolia, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $221.65 | 2019-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $214.58 | 2022-2025 | Xarelto, Spravato |
| Merck Sharp & Dohme LLC | $209.08 | 2019-2024 | Gardasil 9, Capvaxive, Gardasil |
| Teva Pharmaceuticals USA, INC. | $202.38 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $137.11 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $136.14 | 2020-2025 | Trintellix |
| Abbott Laboratories | $93.44 | 2022-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Exact Sciences Corporation | $92.93 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $91.85 | 2022-2023 | |
| Genentech USA, INC. | $88.47 | 2019-2020 | |
| Glaxosmithkline, LLC. | $73.77 | 2019-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Medical Device Business Services, INC. | $71.78 | 2021 | |
| Sanofi-Aventis U.S. LLC | $61.95 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $58.23 | 2022 | |
| Idorsia Pharmaceuticals US INC | $57.96 | 2022-2023 | Quviviq |
| Allergan, INC. | $45.61 | 2019-2020 | |
| Shire North American Group INC | $42.95 | 2019 | |
| Phathom Pharmaceuticals, INC. | $42.69 | 2024-2025 | Voquezna |
| Amarin Pharma, INC. | $41.70 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $31.21 | 2019-2024 | Airsupra |
| Dynavax Technologies Corporation | $30.65 | 2023-2024 | Heplisav-B |
| Medtronic, INC. | $18.51 | 2024 | Intellis Adaptivestim |
| Ibsa Pharma INC. | $17.68 | 2024 | Tirosint, Licart |
| Astellas Pharma US INC | $17.54 | 2025 | Veozah |
| Biohaven Pharmaceuticals, INC. | $15.60 | 2021 | |
| Shionogi INC | $15.33 | 2019 | |
| Stryker Corporation | $15.15 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Inspire Medical Systems, INC. | $13.35 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.